We are monitoring the impact of COVID-19 on Europe Virology Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4931
Share on
Share on

Europe Virology Market Research Report – Segmented By Type, Application, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4931
Pages: 145

The size of the Virology Market in Europe is predicted to hike at a promising CAGR from 2020 to 2025.

Virology refers to the science of viruses, which are sub microscopic, parasitic particles of genetic material in a protein coat, and virus-like agents. Virology mainly aims at the structure, classification, and evolution of viruses, their means of infection and exploitation of host cells for reproduction, their interaction with the host body physiology and immunity, the procedures to isolate and culture them, and their use in research and therapy. Virology is considered as a subfield of microbiology.

The significant drivers are various treatments and diagnostic processes that use virology applications. Increasing virology applications in gene therapy, phage therapy, formulation of vaccines, etc. are also expected to boost the market. Increasing Public awareness programs conducted worldwide on flu, zika virus, STDs, AIDS, and Ebola virus are also key factors driving the market. However, quality and safety standards are a longstanding challenge, and stringent approval processes for antiviral drugs may limit this industry's growth.

This market research report on the Europe Virology Market has been segmented and sub-segmented into the following categories:

  • By Type: Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy and Interferons
  • By Application: Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infections, Eye Infections, CNS Infections, Sexually Transmitted Diseases, and Perinatal Infections
  • By End-User: Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, and Pharmacies
  • By Country: United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, and Rest of Europe

Regionally, Europe is projected to sustain its spot as the second-largest virology market globally. During the forecast period, Europe is forecasted to record the highest CAGR, accredited by improved healthcare infrastructure, aided access to diagnostics, and the growing affordability of diagnostic tests for viral illnesses. Europe region had the highest CAGR owing to improved healthcare infrastructure, increasing access to diagnostics, and growing affordability of diagnostic tests for viral.

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche are some of the key players in the Europe Virology market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. Type
      1. Introduction
      2. Diagnosing Test
        1. DNA Viruses
        2. RNA Viruses
        3. Prions Diagnostic Test
        4. Other Viral Tests
      3. Viral Infection Controlling Methods
        1. Immunoprophylaxis
        2. Active Prophylaxis (Vaccines)
        3. Passive Prophylaxis
      4. Antiviral Chemotherapy
        1. Virucidal Agents
        2. Antiviral Agents
        3. Immunomodulators
      5.                    Interferons
        1. Cytokines
      6. Y-o-Y Growth Analysis, By Type
      7. Market Attractiveness Analysis, By Type                 
      8. Market Share Analysis, By Type
    2. Application           
      1. Introduction
      2. Skin and Soft Tissue Infections
      3. Respiratory Tract Infections
      4. GI Tract Infections
      5. Urinary Tract Infections
      6. Eye Infections
      7. CNS Infections
      8. Sexually Transmitted Diseases
      9. Perinatal Infections
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    3. End User
      1. Introduction
      2. Hospitals
      3. Clinics
      4. Laboratories
      5. Diagnostic Centres
      6. Blood Banks
      7. Pharmacies
      8. Y-o-Y Growth Analysis, By End User
      9. Market Attractiveness Analysis, By End User
      10. Market Share Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Europe
      1. Introduction
      2. United Kingdom
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Russia
      8. Sweden
      9. Denmark
      10. Switzerland
      11. Netherlands
      12. Rest of Europe
    3. STRATEGIC ANALYSIS
      1. PESTLE analysis
        1. Political
        2. Economic
        3. Social
        4. Technological
        5. Legal
        6. Environmental
    4. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  7. MARKET LEADERS' ANALYSIS
    1. Johnson & Johnson
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Abbott Laboratories
    3. GlaxoSmithKline plc
    4. Boehringer Ingelheim Corporation
    5. Merck and Co. Inc.
    6. Novartis International AG
    7. Siemens
    8. AstraZeneca AB
    9. Roche
  8. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  9. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  10. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  2. Europe Diagnosing Test Market, By Region, From 2020 TO 2025 (USD MILLION)
  3. Europe Viral Infection Controlling Methods Market, By Region, From 2020 TO 2025 (USD MILLION)
  4. Europe Antiviral Chemotherapy Market, By Region, From 2020 TO 2025 (USD MILLION)
  5. Europe Interferons Market, By Region, From 2020 TO 2025 (USD MILLION)
  6. Europe Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  7. Europe Respiratory Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  8. Europe GI Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  9. Europe Urinary Tract Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  10. Europe Eye Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  11. Europe CNS Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  12. Europe Sexually Transmitted Diseases Market, By Region, From 2020 TO 2025 (USD MILLION)
  13. Europe Perinatal Infections Market, By Region, From 2020 TO 2025 (USD MILLION)
  14. Europe Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  15. Europe Hospitals Market, By Region, From 2020 TO 2025 (USD MILLION)
  16. Europe Clinics Market, By Region, From 2020 TO 2025 (USD MILLION)
  17. Europe Laboratories Market, By Region, From 2020 TO 2025 (USD MILLION)
  18. Europe Diagnostic Centres Market, By Region, From 2020 TO 2025 (USD MILLION)
  19. Europe Blood Banks Market, By Region, From 2020 TO 2025 (USD MILLION)
  20. Europe Pharmacies Market, By Region, From 2020 TO 2025 (USD MILLION)
  21. U.K. Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  22. U.K. Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  23. U.K. Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  24. Germany Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  25. Germany Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  26. Germany Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  27. France Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  28. France Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  29. France Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  30. Italy Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  31. Italy Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  32. Italy Virology Market, By End User, From 2020 TO 2025 (USD MILLION)
  33. Spain Virology Market, By Type, From 2020 TO 2025 (USD MILLION)
  34. Spain Virology Market, By Application, From 2020 TO 2025 (USD MILLION)
  35. Spain Virology Market, By End User, From 2020 TO 2025 (USD MILLION)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample